Browsing by Subject "prostate cancer"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
Item Computer-aided diagnosis of prostate cancer with multiparametric MRI(2020-07) Leng, EthanProstate cancer (PCa) is a leading cause of cancer death among men in the U.S. Multiparametric magnetic resonance imaging (mpMRI), a combination of anatomic and functional imaging methods, has demonstrated potential to improve PCa detection. However, radiologic interpretation of mpMRI data is time-consuming and highly dependent on reader expertise. Therefore, a computer-aided detection (CAD) system that could accurately and automatically detect PCa using mpMRI data would provide tremendous clinical utility. This dissertation research focuses on the development and improvement of several components of such a CAD system, with topics that include image registration, quantitative pathology, and model development and evaluation.Item PCA3 and Prostate Cancer(2010-07-21) Reddy, AvinashProstate cancer is the most common cancer in men and second leading cause of death due to cancer in men. This pamphlet describes this condition and the screening tests available. Also discussed is the PCA3 test and its role in detecting prostate cancer.Item Prostate-specific antigen is not an effective screening test for prostate cancer(2010-09-15) Barbosa, PhilipThere is not enough evidence to make definitive recommendations for PSA as a screening tool for men younger than 75 years. In depth discussion regarding patient’s definition of quality of life is necessary to address the potential risks and benefits of screening and potential disease. This includes both psychological effects of false positive test as well as physiological side effects of surgery. It is likely that many more years of data will be necessary to correctly evaluate current effectiveness of monitoring protocols. It is necessary to note that PSA screening alone can have serious psychological effects on patients no matter the result.Item PSA Screening for Prostate Cancer.(2009-09-16) McChesney, BrianHealthcare providers should discuss the risks and benefits of prostate cancer screening with the PSA blood test in men who are old enough to be at significant risk for prostate cancer and are expected to live at least 10 years. This pamphlet summarizes the current recommendations for PSA screening.